Search details
1.
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.
Clin Infect Dis
; 2023 Jan 05.
Article
in English
| MEDLINE | ID: mdl-36610728
2.
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.
JAMA
; 314(3): 237-46, 2015 Jul 21.
Article
in English
| MEDLINE | ID: mdl-26197184
3.
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
JAMA
; 312(14): 1420-8, 2014 Oct 08.
Article
in English
| MEDLINE | ID: mdl-25291578
4.
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
J Infect Dis
; 203(5): 666-73, 2011 Mar 01.
Article
in English
| MEDLINE | ID: mdl-21282194
5.
Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
J Infect Dis
; 204(6): 845-53, 2011 Sep 15.
Article
in English
| MEDLINE | ID: mdl-21846636
6.
A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).
Vaccine
; 35(48 Pt B): 6759-6765, 2017 12 04.
Article
in English
| MEDLINE | ID: mdl-29037578
7.
Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.
Vaccine
; 35(13): 1675-1682, 2017 03 23.
Article
in English
| MEDLINE | ID: mdl-28256358
8.
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
Vaccine
; 35(36): 4730-4737, 2017 08 24.
Article
in English
| MEDLINE | ID: mdl-28750854
9.
Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
Vaccine
; 33(1): 163-73, 2015 Jan 01.
Article
in English
| MEDLINE | ID: mdl-25444805
10.
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.
Vaccine
; 33(39): 5225-34, 2015 Sep 22.
Article
in English
| MEDLINE | ID: mdl-26143613
11.
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
Open Forum Infect Dis
; 1(3): ofu102, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25734170
12.
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.
Vaccine
; 29(44): 7733-9, 2011 Oct 13.
Article
in English
| MEDLINE | ID: mdl-21835220
13.
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
Vaccine
; 27(47): 6589-94, 2009 Nov 05.
Article
in English
| MEDLINE | ID: mdl-19716456
14.
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.
Vaccine
; 27(37): 5091-5, 2009 Aug 13.
Article
in English
| MEDLINE | ID: mdl-19577636
15.
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.
J Infect Dis
; 197(5): 667-75, 2008 Mar 01.
Article
in English
| MEDLINE | ID: mdl-18260764
16.
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.
Vaccine
; 26(32): 4057-61, 2008 Jul 29.
Article
in English
| MEDLINE | ID: mdl-18602726
17.
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.
Vaccine
; 25(37-38): 6755-63, 2007 Sep 17.
Article
in English
| MEDLINE | ID: mdl-17692438
18.
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
Vaccine
; 25(44): 7656-63, 2007 Nov 01.
Article
in English
| MEDLINE | ID: mdl-17913310
Results
1 -
18
de 18
1
Next >
>>